↓ Skip to main content

The epidemiology, healthcare and societal burden and costs of asthma in the UK and its member nations: analyses of standalone and linked national databases

Overview of attention for article published in BMC Medicine, August 2016
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (99th percentile)
  • High Attention Score compared to outputs of the same age and source (95th percentile)

Mentioned by

news
20 news outlets
blogs
3 blogs
policy
3 policy sources
twitter
63 X users
facebook
3 Facebook pages

Citations

dimensions_citation
206 Dimensions

Readers on

mendeley
414 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
The epidemiology, healthcare and societal burden and costs of asthma in the UK and its member nations: analyses of standalone and linked national databases
Published in
BMC Medicine, August 2016
DOI 10.1186/s12916-016-0657-8
Pubmed ID
Authors

Mome Mukherjee, Andrew Stoddart, Ramyani P. Gupta, Bright I. Nwaru, Angela Farr, Martin Heaven, Deborah Fitzsimmons, Amrita Bandyopadhyay, Chantelle Aftab, Colin R. Simpson, Ronan A. Lyons, Colin Fischbacher, Christopher Dibben, Michael D. Shields, Ceri J. Phillips, David P. Strachan, Gwyneth A. Davies, Brian McKinstry, Aziz Sheikh

Abstract

There are a lack of reliable data on the epidemiology and associated burden and costs of asthma. We sought to provide the first UK-wide estimates of the epidemiology, healthcare utilisation and costs of asthma. We obtained and analysed asthma-relevant data from 27 datasets: these comprised national health surveys for 2010-11, and routine administrative, health and social care datasets for 2011-12; 2011-12 costs were estimated in pounds sterling using economic modelling. The prevalence of asthma depended on the definition and data source used. The UK lifetime prevalence of patient-reported symptoms suggestive of asthma was 29.5 % (95 % CI, 27.7-31.3; n = 18.5 million (m) people) and 15.6 % (14.3-16.9, n = 9.8 m) for patient-reported clinician-diagnosed asthma. The annual prevalence of patient-reported clinician-diagnosed-and-treated asthma was 9.6 % (8.9-10.3, n = 6.0 m) and of clinician-reported, diagnosed-and-treated asthma 5.7 % (5.7-5.7; n = 3.6 m). Asthma resulted in at least 6.3 m primary care consultations, 93,000 hospital in-patient episodes, 1800 intensive-care unit episodes and 36,800 disability living allowance claims. The costs of asthma were estimated at least £1.1 billion: 74 % of these costs were for provision of primary care services (60 % prescribing, 14 % consultations), 13 % for disability claims, and 12 % for hospital care. There were 1160 asthma deaths. Asthma is very common and is responsible for considerable morbidity, healthcare utilisation and financial costs to the UK public sector. Greater policy focus on primary care provision is needed to reduce the risk of asthma exacerbations, hospitalisations and deaths, and reduce costs.

X Demographics

X Demographics

The data shown below were collected from the profiles of 63 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 414 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 414 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 85 21%
Student > Master 49 12%
Researcher 44 11%
Student > Ph. D. Student 36 9%
Other 22 5%
Other 58 14%
Unknown 120 29%
Readers by discipline Count As %
Medicine and Dentistry 117 28%
Nursing and Health Professions 22 5%
Pharmacology, Toxicology and Pharmaceutical Science 20 5%
Agricultural and Biological Sciences 16 4%
Biochemistry, Genetics and Molecular Biology 15 4%
Other 89 21%
Unknown 135 33%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 223. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 19 October 2021.
All research outputs
#172,906
of 25,446,666 outputs
Outputs from BMC Medicine
#153
of 4,019 outputs
Outputs of similar age
#3,436
of 349,219 outputs
Outputs of similar age from BMC Medicine
#2
of 49 outputs
Altmetric has tracked 25,446,666 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 4,019 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 45.8. This one has done particularly well, scoring higher than 96% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 349,219 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 49 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 95% of its contemporaries.